2016 Communication Vaccines 
Pharmaceutical Technology
MAY 22, 2023
The Covid-19 pandemic saw a proliferation in novel vaccine technologies being produced rapidly. With the emergence of vaccines came accusations of technology encroachment amongst biotech companies. CureVac’s lawsuits add to a complex legal landscape for Pfizer/BioNTech that already includes ones from Moderna.
European Pharmaceutical Review
DECEMBER 19, 2023
Many of today’s vaccines are produced in ready-to-inject liquid formulations that must be kept cold to maintain stability. However, this greatly complicates both the worldwide distribution and stockpiling of vaccines and other drugs. A requisite cold chain has been designed and implemented to be uninterrupted from factory to patient.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
MAY 26, 2021
People can opt out of the scheme by filling in a form and taking it to their GP before 23 June, but campaigners say this has not been communicated effectively. The government’s last attempt to shake up patient data-sharing – 2013’s Care.data scheme – suffered from a number of false starts and was eventually shut down in 2016.
Putting Patients First Blog
APRIL 30, 2024
This method not only prioritizes the participant’s comprehension but also aligns with best practices in health communication that suggests a focused approach can significantly enhance understanding and retention of important information. The importance of using plain language in health communications is well-documented in literature.
pharmaphorum
SEPTEMBER 27, 2021
As the vaccines were developed and rolled out, the disparity in their take up among different sections of the community highlighted how excluded some minority communities felt from areas of healthcare. And then the COVID-19 pandemic really brought it into sharp relief.
pharmaphorum
APRIL 11, 2022
Medicines and vaccines are among the most powerful interventions that can help improve quality of life for people across the world. Data will always be central to everything we do, as it has the power to communicate the potential of a new treatment to change a person’s life.
Eye on FDA
JANUARY 12, 2022
Each year we look back to take stock of how the agency has been communicating in the course of the previous year and assess how that might compare to years gone by. When Dr. Scott Gottlieb took the reins of FDA as Commissioner, the amount of communications material put out jumped enormously. When will the products be fully approved?
Expert insights. Personalized for you.
116 
Let's personalize your content